Zyla Life Sciences Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-06-15: Reporting owner WEAVER GREGORY L; Form 4; Security Common Stock (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-06-15: Reporting owner Radie Robert S; Form 4; Security Common Stock (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-06-10: Reporting owner NICOLAIDES NICHOLAS C; Form 4; Security Common Stock (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-06-10: Reporting owner OSBORN JOHN E; Form 4; Security Common Stock (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-06-15 | WEAVER GREGORY L Director | 4 | Common Stock (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,666 29,666 owned after | $4.98 | 2016-06-17 | |
| 2016-06-15 | Radie Robert S Director, Officer (President and CEO) | 4 | Common Stock (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +265,000 265,000 owned after | $8.59 | 2016-06-17 | |
| 2015-06-10 | NICOLAIDES NICHOLAS C Director | 4 | Common Stock (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.08 exercise price | 2016-07-22 | |
| 2015-06-10 | OSBORN JOHN E Director | 4 | Common Stock (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.08 exercise price | 2016-07-22 | |
| 2015-06-10 | Walbert Timothy P Director | 4 | Common Stock (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.08 | 2016-06-17 |